Label: SULFUR 8 SCALP THERAPY MEDICATED DANDRUFF CONTROL LEAVE-IN SOOTHING TREATMENT- salicylic acid solution

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated October 21, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Active Ingredient

    Salicylic Acid, 2%

    Purpose

    Antidandruff, Seborrheic Dermatitis, Psoriasis

  • Use:

    for relief of scalp itching, irritation, redness, scaling and flaking associated with dandruff, seborrheic dermatitis, psoriasis.

  • Warnings

    For external use only

    Ask a doctor before use

    if the condition covers a large area of the body.

    When using this product

    avoid contact with eyes. If contact, rinse eyes thoroughly with water.

    Stop use and consult a doctor if

    condition worsens or does not improve after regular use of this product as directed.

    Keep out of reach of children.

    If swallowed, get medical help or contact a Poison Control Center right away.

    Keep away from heat and open flame. Flammable

  • Directions

    Apply to the affected area one to four times daily or as directed by a doctor. Use after shampooing or between shampoos.

  • Inactive Ingredients

    Water, SD Alcohol 40, Propylene Glycol, Benzyl Alcohol, Menthol, Fragrance

  • Package Labeling:

    Outer PackageInner Package

  • INGREDIENTS AND APPEARANCE
    SULFUR 8 SCALP THERAPY MEDICATED DANDRUFF CONTROL LEAVE-IN SOOTHING TREATMENT 
    salicylic acid solution
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:12022-033
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID30 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    BENZYL ALCOHOL (UNII: LKG8494WBH)  
    MENTHOL (UNII: L7T10EIP3A)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:12022-033-001 in 1 BOX01/01/2020
    174 mL in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM03201/01/2020
    Labeler - J. Strickland and Co. (007023112)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!